Health Catalyst, Inc.
NASDAQ:HCATMedical - Healthcare Information Services
-$0.04 today
- Market cap
- $98.24M
- Beta
- 1.66
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$3.65
Volume 0.27M
Average 1.24M
HCAT Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Health Catalyst, Inc.NASDAQ: HCAT
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt rises 83.3% from a year ago
Net debt stood at $110.71M at the end of Q1 FY2026, up 83.3% from a year earlier and down 8.1% from the prior quarter. Over 3 fiscal years it compounded at -2.9% a year.
Context
- Net debt amounted to 26.9% of total assets at the end of Q1 FY2026, up 20.1 pp from a year earlier.
- Net debt increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net debt keeps rising in the next quarterly balance sheet after a +83.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- 120.42M USD
- Year-over-year change
- -21.1%
- 4-year CAGR
- +80.3%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 120.42M | -21.1% |
| FY2024 | 2024-12-31 | 152.62M | +6.9% |
| FY2023 | 2023-12-31 | 142.79M | +8.5% |
| FY2022 | 2022-12-31 | 131.66M | +1056.6% |
| FY2021 | 2021-12-31 | 11.38M | — |
Net Debt vs competitors
How HCAT compares with its peers on the latest reported figures
- HCAT's Mar 2026 net debt of $110.71M is the 2nd highest of the 11 companies compared; the peer median is $8.14M.
- Its year-over-year change of +83.3% is the 4th highest of 11, against a peer median of +26.4%.
- Net debt amounts to 26.9% of total assets for HCAT, versus a peer median of 21.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $151.69M | -2.7% | — | 48.2% | |
| Mar 2026 | $110.71M | +83.3% | -2.9% | 26.9% | |
| Mar 2026 | $71.05M | +219.5% | +30.2% | 28.5% | |
| Mar 2026 | $14.89M | +566.3% | — | 10.0% | |
| Mar 2026 | $11.39M | -38.0% | -33.7% | 30.7% | |
| Mar 2026 | $11.02M | +55.6% | — | 17.1% | |
| Mar 2026 | $5.27M | +376.7% | — | 5.2% | |
| Mar 2026 | -$4.04M | +81.9% | — | 3.4% | |
| Mar 2026 | -$4.4M | -296.3% | — | 2.2% | |
| Dec 2025 | -$41.3M | -29.6% | — | 25.5% | |
| Mar 2026 | -$70.77M | -73.2% | — | 52.4% | |
| Peer median (excluding HCAT) | $8.14M | +26.4% | -1.8% | 21.3% | |
Competitors are the stored peer set for HCAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 193.23M | 116.31M | 106.28M | 249.65M | 50.81M |
| Short-term Investments | 251.75M | 247.18M | 211.45M | 142.36M | 44.92M |
| Net Receivables | 48.8M | 47.97M | 60.29M | 57.18M | 59.13M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 14.61M | 16.34M | 15.38M | 16.47M | 14.45M |
| Total Current Assets | 508.39M | 427.8M | 393.4M | 465.65M | 169.31M |
| Property, Plant & Equipment (Net) | 44.45M | 42.59M | 39.64M | 41.45M | 40.48M |
| Goodwill | 169.97M | 185.98M | 190.65M | 259.76M | 209.07M |
| Intangible Assets | 104.79M | 92.19M | 73.38M | 86.05M | 77.68M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 4.5M | 3.73M | 4.74M | 6.02M | 6.11M |
| Total Non-current Assets | 323.71M | 324.49M | 308.42M | 393.28M | 333.34M |
| Total Assets | 832.1M | 752.29M | 701.81M | 858.93M | 502.64M |
| Account Payables | 4.69M | 4.42M | 6.64M | 11.43M | 9.36M |
| Short-term Debt | 0 | 0 | 0 | 231.18M | 1.63M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 56.63M | 54.96M | 55.75M | 53.28M | 56.11M |
| Other Current Liabilities | 10.87M | 7.51M | 11.68M | 11.66M | 5.2M |
| Total Current Liabilities | 93.05M | 82.51M | 89.03M | 325.85M | 89.57M |
| Long-term Debt | 180.94M | 226.52M | 228.03M | 151.18M | 151.62M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 929K | 105K | 77K | 249K | 410K |
| Other Non-current Liabilities | 14.83M | 121K | 74K | 154K | 798K |
| Total Non-current Liabilities | 216.95M | 244.77M | 245.86M | 167.87M | 167.29M |
| Total Liabilities | 310M | 327.28M | 334.9M | 493.72M | 256.86M |
| Common Stock | 53K | 1.42B | 1.48B | 1.55B | 1.61B |
| Retained Earnings | (878.86M) | (999.02M) | (1.12B) | (1.19B) | (1.36B) |
| Accumulated OCI | (67K) | (648K) | 33K | (835K) | 1.59M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 522.1M | 425.01M | 366.92M | 365.21M | 245.78M |
| Total Debt | 204.61M | 247.97M | 249.07M | 402.27M | 171.24M |
| Net Debt | 11.38M | 131.66M | 142.79M | 152.62M | 120.42M |
Health Catalyst, Inc.
NASDAQ:HCAT
Intrinsic Alpha fair value
Locked
Current Price
$1.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.